Avastin [bevacizumab] and Chemotherapy Followed by Avastin Alone or in Combination With Tarceva [erlotinib] for the Treatment of Metastatic Colorectal Cancer.

Trial Profile

Avastin [bevacizumab] and Chemotherapy Followed by Avastin Alone or in Combination With Tarceva [erlotinib] for the Treatment of Metastatic Colorectal Cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Oct 2015

At a glance

  • Drugs Bevacizumab (Primary) ; Capecitabine; Erlotinib; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
  • Indications Colorectal cancer
  • Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
  • Acronyms ACT; ACT2
  • Most Recent Events

    • 17 Aug 2012 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database.
    • 04 Jun 2012 Results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
    • 13 Jun 2011 Planned end date changed from 1 Jun 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top